Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients
Open Access
- 22 November 2010
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 8 (1) , 122
Abstract
To evaluate fluorescence cystoscopy with hexaminolevulinate (HAL) in the early detection of dysplasia (DYS) and carcinoma in situ (CIS) in select high risk patients.Keywords
This publication has 32 references indexed in Scilit:
- Bladder Cancer: A Major Public Health IssueEuropean Urology Supplements, 2008
- A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter StudyJournal of Urology, 2007
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- IMPROVED DETECTION AND TREATMENT OF BLADDER CANCER USING HEXAMINOLEVULINATE IMAGING: A PROSPECTIVE, PHASE III MULTICENTER STUDYJournal of Urology, 2005
- Improved Detection of Urothelial Carcinoma In Situ With Hexaminolevulinate Fluorescence CystoscopyJournal of Urology, 2004
- Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter studyJournal of Urology, 2003
- Role of 5‐aminolevulinic acid in the detection of urothelial premalignant lesionsCancer, 2002
- Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into ProtoporphyrinPhotochemistry and Photobiology, 1998
- Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, 1996
- Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancerEuropean Journal of Cancer, 1994